IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism.

PubWeight™: 2.24‹?› | Rank: Top 2%

🔗 View Article (PMID 12646658)

Published in J Immunol on April 01, 2003

Authors

Beatriz Rendon-Mitchell1, Mahendar Ochani, Jianhua Li, Jialian Han, Hong Wang, Huan Yang, Seenu Susarla, Christopher Czura, Robert A Mitchell, Guoqian Chen, Andrew E Sama, Kevin J Tracey, Haichao Wang

Author Affiliations

1: Center of Immunology and Inflammation, North Shore-Long Island Jewish Research Institute, Manhasset, NY 11030, USA.

Articles citing this

HMGB1: endogenous danger signaling. Mol Med (2008) 4.02

Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med (2006) 2.27

High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal (2011) 2.19

Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol (2006) 2.17

HMGB1 in health and disease. Mol Aspects Med (2014) 1.67

Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats. Crit Care Med (2009) 1.67

A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. J Immunol (2007) 1.60

Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol Med (2009) 1.52

Nuclear heat shock protein 72 as a negative regulator of oxidative stress (hydrogen peroxide)-induced HMGB1 cytoplasmic translocation and release. J Immunol (2007) 1.48

Bench-to-bedside review: latest results in hemorrhagic shock. Crit Care (2008) 1.47

The anti-inflammatory effects of heat shock protein 72 involve inhibition of high-mobility-group box 1 release and proinflammatory function in macrophages. J Immunol (2007) 1.43

EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. Biochem Pharmacol (2011) 1.41

The aqueous extract of a popular herbal nutrient supplement, Angelica sinensis, protects mice against lethal endotoxemia and sepsis. J Nutr (2006) 1.38

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Arthritis Res Ther (2011) 1.33

Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. Am J Respir Cell Mol Biol (2009) 1.32

JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci U S A (2014) 1.31

A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1. PLoS One (2007) 1.30

Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev Mol Med (2008) 1.30

Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis. World J Surg (2006) 1.30

PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat Commun (2014) 1.29

Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock (2009) 1.29

The DEK nuclear autoantigen is a secreted chemotactic factor. Mol Cell Biol (2006) 1.27

Role of HMGB1 in cardiovascular diseases. Curr Opin Pharmacol (2006) 1.26

A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation. PLoS One (2011) 1.25

Extracellular high mobility group box-1 (HMGB1) inhibits enterocyte migration via activation of Toll-like receptor-4 and increased cell-matrix adhesiveness. J Biol Chem (2009) 1.16

Bench-to-bedside review: High-mobility group box 1 and critical illness. Crit Care (2007) 1.14

Alarmins, inflammasomes and immunity. Biomed J (2013) 1.13

Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J Matern Fetal Neonatal Med (2011) 1.13

Role of ERK map kinase and CRM1 in IL-1beta-stimulated release of HMGB1 from cortical astrocytes. Glia (2010) 1.09

HMGB1 in renal ischemic injury. Am J Physiol Renal Physiol (2012) 1.07

Immunomodulatory drugs regulate HMGB1 release from activated human monocytes. Mol Med (2010) 1.02

Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients--a prospective clinical study. Arthritis Res Ther (2008) 1.00

Computational and systems biology in trauma and sepsis: current state and future perspectives. Int J Burns Trauma (2012) 0.99

Targeting HMGB1 in the treatment of sepsis. Expert Opin Ther Targets (2014) 0.99

Tanshinone IIA sodium sulfonate facilitates endocytic HMGB1 uptake. Biochem Pharmacol (2012) 0.98

Potential role of high mobility group box 1 in viral infectious diseases. Viral Immunol (2006) 0.98

HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells. Cell Death Differ (2011) 0.96

Anti-inflammatory role of fetuin-A in injury and infection. Curr Mol Med (2012) 0.96

Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE. J Matern Fetal Neonatal Med (2012) 0.94

Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev Clin Immunol (2014) 0.94

Peripheral administration of fetuin-A attenuates early cerebral ischemic injury in rats. J Cereb Blood Flow Metab (2009) 0.93

High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation. Inflamm Allergy Drug Targets (2010) 0.92

Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damage. Redox Biol (2014) 0.92

Carbenoxolone blocks endotoxin-induced protein kinase R (PKR) activation and high mobility group box 1 (HMGB1) release. Mol Med (2013) 0.92

Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome. Clin Exp Immunol (2013) 0.91

More tea for septic patients?--Green tea may reduce endotoxin-induced release of high mobility group box 1 and other pro-inflammatory cytokines. Med Hypotheses (2005) 0.91

ATG4B/autophagin-1 regulates intestinal homeostasis and protects mice from experimental colitis. Autophagy (2013) 0.90

Gene expression profiling in monocytes and SNP association suggest the importance of the STAT1 gene for osteoporosis in both Chinese and Caucasians. J Bone Miner Res (2010) 0.90

Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza. Evid Based Complement Alternat Med (2009) 0.90

High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1. Thromb Haemost (2009) 0.90

HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol (2016) 0.89

It Is Not Just Folklore: The Aqueous Extract of Mung Bean Coat Is Protective against Sepsis. Evid Based Complement Alternat Med (2012) 0.89

Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain. Mol Med (2015) 0.88

Deacetylation-mediated interaction of SIRT1-HMGB1 improves survival in a mouse model of endotoxemia. Sci Rep (2015) 0.86

Novel Mechanisms of Herbal Therapies for Inhibiting HMGB1 Secretion or Action. Evid Based Complement Alternat Med (2015) 0.84

The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Mol Med (2014) 0.84

Blockade of high-mobility group box-1 ameliorates acute on chronic liver failure in rats. Inflamm Res (2013) 0.82

Cisplatin protects against acute liver failure by inhibiting nuclear HMGB1 release. Int J Mol Sci (2013) 0.82

The compromise of macrophage functions by hyperoxia is attenuated by ethacrynic acid via inhibition of NF-κB-mediated release of high-mobility group box-1. Am J Respir Cell Mol Biol (2015) 0.82

Role of high-mobility group box 1 in patients with acute obstructive suppurative cholangitis-induced sepsis. J Inflamm Res (2015) 0.82

Neuropeptide modulators of high mobility group box 1 secretion as potential therapeutic agents for severe sepsis. Am J Pathol (2008) 0.82

Inhibitions of NF-κB and TNF-α result in differential effects in rats with acute on chronic liver failure induced by d-Gal and LPS. Inflammation (2014) 0.82

Xuebijing Injection Promotes M2 Polarization of Macrophages and Improves Survival Rate in Septic Mice. Evid Based Complement Alternat Med (2015) 0.82

Evaluation of high mobility group box 1 protein as a presurgical diagnostic marker reflecting the severity of acute appendicitis. Scand J Trauma Resusc Emerg Med (2012) 0.81

Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation. Front Immunol (2015) 0.81

Use of animal model of sepsis to evaluate novel herbal therapies. J Vis Exp (2012) 0.81

Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells. World J Gastroenterol (2011) 0.81

Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice. J Virol (2008) 0.81

High mobility group box 1 protein induction by Mycobacterium bovis BCG. Mediators Inflamm (2007) 0.81

The potential role of HMGB1 release in peritoneal dialysis-related peritonitis. PLoS One (2013) 0.81

Staphylococcal toxic shock syndrome toxin-1 induces the translocation and secretion of high mobility group-1 protein from both activated T cells and monocytes. Mediators Inflamm (2008) 0.79

Molecular Targets Underlying the Anticancer Effects of Quercetin: An Update. Nutrients (2016) 0.79

The effect of dexamethasone on the generation of plasma DNA from dead and dying cells. Am J Pathol (2004) 0.79

Induction of arthritis by high mobility group box chromosomal protein 1 is independent of tumour necrosis factor signalling. Arthritis Res Ther (2008) 0.79

Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1. Int J Clin Exp Med (2008) 0.78

Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa. Vasc Health Risk Manag (2006) 0.77

Serum Amyloid A Stimulates PKR Expression and HMGB1 Release Possibly through TLR4/RAGE Receptors. Mol Med (2015) 0.77

High-mobility-group box chromosomal protein 1 as a new target for modulating stress response. Surg Today (2010) 0.77

Cloning and characterization of high mobility group box protein 1 (HMGB1) of Wuchereria bancrofti and Brugia malayi. Parasitol Res (2012) 0.77

Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives. Front Immunol (2016) 0.77

Etanercept decreases HMGB1 expression in dorsal root ganglion neuron cells in a rat chronic constriction injury model. Exp Ther Med (2012) 0.77

Regulation of Posttranslational Modifications of HMGB1 During Immune Responses. Antioxid Redox Signal (2016) 0.77

Ionizing Radiation Induces HMGB1 Cytoplasmic Translocation and Extracellular Release. Guo Ji Fang She Yi Xue He Yi Xue Za Zhi (2016) 0.76

Respiratory Syncytial Virus Infection Triggers Epithelial HMGB1 Release as a Damage-Associated Molecular Pattern Promoting a Monocytic Inflammatory Response. J Virol (2016) 0.76

High mobility group box 1 induces the activation of the Janus kinase 2 and signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway in pancreatic acinar cells in rats, while AG490 and rapamycin inhibit their activation. Bosn J Basic Med Sci (2016) 0.76

High-Density Lipoprotein (HDL) Counter-Regulates Serum Amyloid A (SAA)-Induced sPLA2-IIE and sPLA2-V Expression in Macrophages. PLoS One (2016) 0.75

High-mobility group box 1 is associated with neurological outcome in patients with post-cardiac arrest syndrome after out-of-hospital cardiac arrest. J Intensive Care (2016) 0.75

Mesenchymal Stem Cells Attenuate NADPH Oxidase-Dependent High Mobility Group Box 1 Production and Inhibit Abdominal Aortic Aneurysms. Arterioscler Thromb Vasc Biol (2016) 0.75

The in Vitro Immune-Modulating Properties of a Sweat Gland-Derived Antimicrobial Peptide Dermcidin. Shock (2016) 0.75

An ongoing search for potential targets and therapies for lethal sepsis. Mil Med Res (2015) 0.75

Necroptosis is a key mediator of enterocytes loss in intestinal ischaemia/reperfusion injury. J Cell Mol Med (2016) 0.75

Emerging role of HMGB1 in lung diseases: friend or foe. J Cell Mol Med (2016) 0.75

EGCG induces G-CSF expression and neutrophilia in experimental sepsis. Immunol Res (2015) 0.75

The potential curative effect of rebamipide in hepatic ischemia/reperfusion injury. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75

Articles by these authors

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature (2002) 12.09

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol (2005) 11.57

Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A (2003) 7.14

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 6.86

Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med (2004) 6.38

HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol (2011) 6.23

Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science (2011) 5.87

Sepsis definitions: time for change. Lancet (2013) 5.63

The metabolic syndrome. Endocr Rev (2008) 5.33

MIF signal transduction initiated by binding to CD74. J Exp Med (2003) 4.79

Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med (2008) 4.72

Endogenous HMGB1 regulates autophagy. J Cell Biol (2010) 4.71

HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock (2006) 4.53

Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet (2013) 3.83

Abnormal cerebral structure is present at term in premature infants. Pediatrics (2005) 3.81

A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A (2010) 3.80

Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med (2003) 3.75

Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell (2009) 3.69

Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A (2002) 3.68

Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med (2006) 3.66

A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4. Nat Genet (2010) 3.63

Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med (2007) 3.63

Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med (2005) 3.58

Theoretical, empirical and practical approaches to resolving the unmet information needs of clinical information system users. Proc AMIA Symp (2002) 3.45

Comparative analysis of a large dataset indicates that internal transcribed spacer (ITS) should be incorporated into the core barcode for seed plants. Proc Natl Acad Sci U S A (2011) 3.41

Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med (2007) 3.27

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med (2013) 3.27

Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med (2006) 3.26

Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS (2007) 3.18

Novel role of PKR in inflammasome activation and HMGB1 release. Nature (2012) 3.13

A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood (2007) 3.09

The cytokine activity of HMGB1. J Leukoc Biol (2005) 3.02

Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem (2002) 3.02

Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med (2005) 3.01

HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology (2002) 2.95

The "cytokine profile": a code for sepsis. Trends Mol Med (2005) 2.89

Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med (2012) 2.89

Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol (2010) 2.88

Correlates of axial gout: a cross-sectional study. J Rheumatol (2012) 2.86

Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med (2002) 2.83

Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology (2015) 2.81

Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. J Natl Cancer Inst (2006) 2.79

Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med (2012) 2.79

Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell (2013) 2.69

Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol (2010) 2.65

Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis (2010) 2.64

Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci U S A (2008) 2.58

Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin Cancer Res (2007) 2.52

Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol (2003) 2.50

Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. Mol Cell (2009) 2.50

Use of online resources while using a clinical information system. AMIA Annu Symp Proc (2003) 2.49

The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology (2006) 2.47

Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev (2007) 2.46

High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol (2006) 2.44

Local, persistent activation of Rho GTPases during plasticity of single dendritic spines. Nature (2011) 2.42

Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med (2007) 2.41

Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Mol Cell Biol (2004) 2.33